NFATC1 and non-small cell lung carcinoma: Altogether, all above results convincingly demonstrated that miR‐338 inhibited cell proliferation and EMT in NSCLC cells by down‐regulation of NFATc1, and miR‐338 targeting NFATc1 was responsible for inhibition of the proliferation and EMT of NSCLC cells.